Use cautionDrug recall · FDA · Published July 25, 2022
Sun Pharma Recalls Pantoprazole Due to Discoloration
Sun Pharmaceutical recalls Pantoprazole Sodium 40mg packets (Lot MHC1317A) due to discoloration. Check your medication and contact the manufacturer for details.
Sun Pharmaceutical Industries Inc. is recalling Pantoprazole Sodium for Delayed-Release Oral Suspension, 40 mg, because of discoloration. The affected product was distributed nationwide in the USA. The recall covers Lot # MHC1317A with an expiration date of 07/2023. Read more at govinfonow.com/recall/34393-sun-pharma-recalls-pantoprazole-due-to-discoloration.
“Sun Pharma Recalls Pantoprazole Due to Discoloration.” GovInfoNow, updated October 10, 2026. https://govinfonow.com/recall/34393-sun-pharma-recalls-pantoprazole-due-to-discoloration. Based on FDA recall #D-0068-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0068-2023%22&limit=1).
The FDA announced on July 25, 2022, that Sun Pharmaceutical Industries Inc. voluntarily recalled Pantoprazole Sodium for Delayed-Release Oral Suspension due to discoloration hazards. Owners should stop using the product immediately.
How to tell if you have it
Brand: Sun Pharmaceutical Industries
Product: Pantoprazole Sodium Oral Suspension
Strength: 40 mg
NDC: 62756-071-60
Lot #: MHC1317A
Expiration: 07/2023
The hazard
The recall addresses discoloration in the oral suspension packets. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Sun Pharmaceutical Industries Inc. has 93 other recalls on record since May 21, 2013. Recent brand recalls include Nystatin Cream (Sept. 14, 2026), Carbamazepine Tablets (Aug. 3, 2026), and Perampanel 6mg Tablets (June 17, 2026). Other recent recalls of similar products include Hetero Labs Pantoprazole Tablets (March 26, 2026), Baxter Pantoprazole Sodium Injection (Aug. 6, 2026), and Lupin prednisolone acetate ophthalmic suspension (June 4, 2026).
How to tell if you have this one
Check for Pantoprazole Sodium for Delayed-Release Oral Suspension, 40 mg packets distributed by Sun Pharmaceutical Industries, Inc. Look for NDC 62756-071-60 and Lot # MHC1317A with an expiration date of 07/2023.
Brand
Sun Pharmaceutical Industries
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Medication
Verify if your Pantoprazole Sodium packets match Lot # MHC1317A and NDC 62756-071-60.
Contact Manufacturer
The remedy is not stated in the record; contact Sun Pharmaceutical Industries Inc. for further instructions.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0068-2023 (July 25, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0068-2023 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.